Jury Sides With Novartis In Widow's Bone Drug Suit

Law360, New York (May 26, 2011, 1:37 PM EDT) -- A federal jury in New York on Wednesday sided with Novartis Pharmaceuticals Corp. against a widow claiming Zometa caused her husband's jaw disease, in the first federal trial involving a multiple myeloma patient stemming from the multidistrict litigation over the bone cancer drug.

After a seven-day trial and five hours of deliberation, the jury found Karlene Hogan had not produced enough evidence to prove Zometa had caused her late husband's osteonecrosis of the jaw, a condition that causes the jawbone to deteriorate.

Hogan's suit was remanded...
To view the full article, register now.




Case Information

Case Title

Hogan v. Novartis Pharmaceuticals Corporation

Case Number



New York Eastern

Nature of Suit

Personal Inj. Prod. Liability


Brian M. Cogan

Date Filed

January 19, 2006

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.